In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...
By Mariam Sunny and Christy Santhosh Aug 25 (Reuters) - The personalized cancer vaccine being developed by Moderna and Merck ...
The Food and Drug Administration just approved the new type of flu vaccine for adults ages 50 and older. It relies on the same technology as many Covid-19 jabs. However, it’s unclear whether insurance ...
The Print on MSN
Merck-Moderna mRNA vaccine cuts risk of melanoma returning or spreading in Phase 3 trial. How it works
The personalised cancer vaccine was given alongside Merck’s immunotherapy Keytruda to patients whose melanoma had been ...
8don MSNOpinion
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines threatens their potential
False narratives could undermine public confidence in an important tool that may help prevent or treat cancer in the future.
Skin cancer vaccine V940 is a personalised mRNA therapy being studied for melanoma. Know how it works, its benefits and ...
A positive trial holds promise for treating people with cancer. More research is needed to get effective vaccines to the ...
For older adults, the flu vaccine could look a little different this year.
A new study showed that intismeran, when administered along with immunotherapy drug Keytruda, reduced the risk of death owing ...
Previously, the COVID-19 immunizations made by Pfizer and Moderna were the only mRNA vaccines on the market.
Moderna (NasdaqGS:MRNA) received FDA approval for updated Spikevax and mNEXSPIKE COVID-19 vaccines tailored to the latest SARS-CoV-2 subvariant. The FDA also cleared mFlusiva, Moderna's first mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results